Loading...
Docoh

Calyxt (CLXT)

Calyxt, based in Roseville, Minnesota, is a technology company with a mission to deliver plant-based innovations for a better world. Founded in 2010, Calyxt uses its proprietary TALEN® gene editing technology to work with world-class partners via technology licensing, product development, and seed sale arrangements to revolutionize the way the world uses plants to solve problems.

CLXT stock data

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

4 Aug 22
1 Oct 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 11.91M 11.91M 11.91M 11.91M 11.91M 11.91M
Cash burn (monthly) 1.99M 547.17K 2.26M 2.27M 1.62M 1.57M
Cash used (since last report) 6.08M 1.67M 6.9M 6.94M 4.97M 4.8M
Cash remaining 5.83M 10.24M 5.02M 4.98M 6.95M 7.11M
Runway (months of cash) 2.9 18.7 2.2 2.2 4.3 4.5

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
19 Sep 22 Yves J Ribeill Common Stock Sell Dispose S No Yes 0.2391 30,000 7.17K 99,225
27 Jul 22 Michael A. Carr Common Stock Payment of exercise Dispose F No No 0.22 4,059 892.98 423,941
13 Jun 22 Christopher J Neugent Stock Option (Right-to-Buy) Common Stock Grant Acquire A No No 0.3032 36,400 11.04K 36,400
13 Jun 22 Nelson Kimberly K. Stock Option (Right-to-Buy) Common Stock Grant Acquire A No No 0.3032 37,100 11.25K 37,100
13 Jun 22 Anna Ewa Kozicz-Stankiewicz Stock Option (Right-to-Buy) Common Stock Grant Acquire A No No 0.3032 34,900 10.58K 34,900
73.8% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 41 42 -2.4%
Opened positions 5 8 -37.5%
Closed positions 6 15 -60.0%
Increased positions 8 13 -38.5%
Reduced positions 18 13 +38.5%
13F shares Current Prev Q Change
Total value 108.06M 120.03M -10.0%
Total shares 34.55M 33.78M +2.3%
Total puts 0 14.3K EXIT
Total calls 13.61K 28K -51.4%
Total put/call ratio 0.5
Largest owners Shares Value Change
CLLS Cellectis 23.96M $94.89M 0.0%
FMR 2.61M $2.71M -7.2%
Armistice Capital 2.28M $2.38M NEW
Uniplan Investment Counsel 1.21M $1.25M +1.0%
CMTDF Sumitomo Mitsui Trust 1.1M $1.14M -17.1%
Nikko Asset Management Americas 1.1M $1.16M -17.1%
Regents Of The University Of California 501.8K $522K 0.0%
Millennium Management 294.96K $307K +20.2%
Vanguard 272.82K $284K -48.8%
Two Sigma Advisers 232.6K $242K -40.8%
Largest transactions Shares Bought/sold Change
Armistice Capital 2.28M +2.28M NEW
Vanguard 272.82K -259.95K -48.8%
CMTDF Sumitomo Mitsui Trust 1.1M -226.63K -17.1%
Nikko Asset Management Americas 1.1M -226.63K -17.1%
FMR 2.61M -202K -7.2%
Two Sigma Advisers 232.6K -160.5K -40.8%
Two Sigma Investments 147.74K -114.6K -43.7%
Marshall Wace 0 -84.57K EXIT
Renaissance Technologies 17.9K -63.5K -78.0%
MS Morgan Stanley 25.02K -61.85K -71.2%

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: assurance, bid, confidence, Conversely, CPG, delisted, Delisting, exposed, fairvalue, footprint, forfeited, formal, inflation, investor, listed, listing, maximizing, met, passed, permanent, procured, proportion, refocused, remeasured, restated, reverse, Rule, satisfy, solution, spent, split
Removed: April, CEO, commercialize, eligible, enabling, insurance, issuable, leading, move, President, produced, stage, Vice